FTC Tells Justices Pay-For-Delay 'Presumptively Unlawful'

Law360, New York (January 23, 2013, 5:01 PM EST) -- The Federal Trade Commission told the U.S. Supreme Court on Tuesday that pay-for-delay settlements should be presumed anti-competitive and that they circumvent lawmakers' intent to keep drug costs low through market competition, comparing the deals to more traditional horizontal business arrangements that flout antitrust laws.  

The FTC, a long-time opponent of pay-for-delay settlements, filed a petitioners brief with the Supreme Court in a case challenging patent settlements Solvay Pharmaceuticals Inc. inked with several generic drugmakers to protect its low-testosterone treatment, AndroGel. The court has agreed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.